Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal
Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal
Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance.